Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial

Antonin Lévy, Éric Deutsch, Jean‐Pierre Pignon et al.|Radiotherapy and Oncology|2015

Cited by 38